This transition is marked by increased expression of pro-inflammatory cytokines (e.g., TNF-α, IL-12) and enhanced ROS-mediated cytotoxicity, leading to tumor cell apoptosis and delayed tumor progression in murine models [84]. The gene discussed is TNF; the disease is neoplasm.